Bombay HC: Insolvency Cannot be Used to Evade a Family Court’s Maintenance Order  ||  Kerala HC: Forklifts and Factory Cranes Are Motor Vehicles and Must be Registered under MV Act  ||  Guj HC: Edible Crude Palm Kernel Oil Qualifies for Duty Exemption; End-Use Condition not Applicable  ||  NCLAT Delhi: Advance under Land-Development MoU is not Financial Debt and Cannot Trigger CIRP  ||  NCLAT: NCLT Cannot Change Capital Structure of a Legally Compliant Successful Auction Purchaser  ||  Supreme Court: Endless Investigation and Long Delay in Filing Chargesheet Can Justify Quashing Case  ||  SC: Landowners Accepting Compensation Settlements Cannot Later Claim Statutory Benefits  ||  Supreme Court: Provident Fund Dues Have Priority over a Bank’s Claim under the SARFAESI Act  ||  Supreme Court: Indian Courts Cannot Appoint Arbitrators for Arbitrations Seated Outside India  ||  Madras HC: Police Superintendent not Liable For IO’s Delay In Filing Chargesheet or Closure Report    

Cabinet approves MoU between India and Uzbekistan on cooperation for establishment of Uzbek-Indian Free Pharmaceutical Zone in the Andijan region of Uzbekistan- (Press Information Bureau) (26 Sep 2018)

MANU/PIBU/1352/2018

Law of Medicine

The Union Cabinet chaired by Prime Minister Shri Narendra Modi has approved the Memorandum of Understanding (MoU) between India and Uzbekistan for establishment of the Uzbek-Indian Free Pharmaceutical Zone in the Andijan Region of Uzbekistan. The MoU will be signed during the visit of President of Uzbekistan to India on 1st October 2018.

In view of the importance of the growth of the pharmaceuticals and biopharmaceutical industry in both countries and the importance of mutual cooperation in trade, industry and production in the pharmaceutical and biopharmaceutical sectors, both the countries have been trying to establish a formal mechanism of bilateral cooperation. The MoU will create an enabling framework of cooperation for setting up an Uzbek-Indian Free Pharmaceuticals Zone in Andijan region of Uzbekistan. It will also facilitate Indian pharmaceutical and biopharmaceutical companies to invest in and establish production facilities in the Uzbek-Indian Free Pharma Zone of Andijan for manufacture of Pharmaceutical Products.

Tags : MOU   APPROVAL   PHARMACEUTICAL ZONE  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved